Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FertyBiotic Embarazo (also known as FertyBiotic Pregnancy) is a multi-ingredient probiotic-based dietary supplement developed by Fertypharm to support maternal and fetal health. Designed for use during preconception, pregnancy, and lactation, the product combines essential nutrients including docosahexaenoic acid (DHA), folic acid (as Quatrefolic), iodine, iron, zinc, magnesium, and a range of vitamins (B1, B2, B3, B5, B6, B12, C, D3, E, and biotin). A distinguishing feature of the formulation is the inclusion of specific probiotic strains, *Lactobacillus rhamnosus* BPL205 and *Lactobacillus reuteri* BPL206, which are intended to maintain healthy gastrointestinal and vaginal microbiota. The supplement is administered as a daily oral soft gelatin capsule to support normal fetal brain and eye development, prevent neural tube defects, and meet the increased nutritional demands of the mother.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on FertyBiotic Embarazo.